The International AIDS Vaccine Initiative (IAVI) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator

2021 ◽  
pp. 100-117
Author(s):  
Joanna Chataway ◽  
Stefano Brusoni ◽  
Eugenia Cacciatori ◽  
Rebecca Hanlin ◽  
Luigi Orsenigo
Keyword(s):  
Vaccine Development ◽  
Public Private Partnership ◽  
Knowledge Broker ◽  
Private Partnership ◽  
International Aids ◽  
Aids Vaccine

scholarly journals To Boldly Remember Where We Have Already Been

2020 ◽  
Vol 2 (1-2) ◽  
pp. 17-35
Author(s):  
Nathaniel L. Moir
Keyword(s):  
United States ◽  
Mass Production ◽  
Vaccine Development ◽  
The United States ◽  
Public Private Partnership ◽  
Polio Virus ◽  
Private Partnership ◽  
The Public ◽  
Polio Vaccine ◽  
Current Vaccine

Abstract This article revisits the Cutter Incident in the United States in April 1955 when mass-produced doses of polio vaccine containing insufficiently inactivated (killed) live polio virus were released to the U.S. public. The Cutter Incident also affected subsequent vaccine development and these lessons remain relevant in the international quest to create a rapidly developed vaccine for COVID-19. The Cutter Incident shows how things can go wrong when a vaccine is manufactured in haste and without adequate safety precautions during mass-production. In the article’s later section, liability without fault, among other consequences resulting from the incident, are also assessed in the context of current vaccine development through Operation Warp Speed, the public-private partnership funded by the U.S. government to develop a remedy for COVID-19.

scholarly journals SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System

2021 ◽  
Vol 9 ◽  
Author(s):  
Elissa R. Weitzman ◽  
Amy C. Sherman ◽  
Ofer Levy
Keyword(s):  
Drug Administration ◽  
Review Process ◽  
Vaccine Development ◽  
Food And Drug Administration ◽  
Public Private Partnership ◽  
System Model ◽  
The Novel ◽  
Private Partnership ◽  
Academic Partnerships ◽  
The U.S

As part of the U.S. Food and Drug Administration COVID-19 vaccine review process, public commentary was solicited offering an opportunity to reflect on vaccine attitudes that may impact the uptake of coronavirus vaccines. We identified themes in the commentary that highlighted the safety, efficacy, ethics, and trustworthiness and transparency regarding the novel mRNA COVID-19 vaccines. A “Learning Immunization System” model is proposed to optimize public, private, and academic partnerships relating to vaccine development and implementation.

Sign in / Sign up

Export Citation Format

Share Document